49-year-old woman with bone pain and a waddling gait
A 49-year-old woman evaluates progressive bone pain and muscle weakness. Six years after a Roux-en-Y gastric bypass, she developed diffuse pelvic and leg pain, difficulty climbing train station stairs, and rising from her office chair. Three months ago, a dual-energy x-ray absorptiometry scan showed a T-score of -2.7; weekly alendronate was started, but perioral numbness and bone pain ensued. Examination shows diffuse tibial and rib tenderness, 4/5 hip flexor weakness, a positive Chvostek sign, and a waddling gait. Laboratory studies: Calcium: 7.8 mg/dL Albumin: 4.1 g/dL Phosphorus: 1.8 mg/dL Alkaline phosphatase: 242 U/L Intact parathyroid hormone: 174 pg/mL 25-hydroxyvitamin D: 6 ng/mL Creatinine: 0.74 mg/dL Which of the following is the most appropriate next step in management?
See the answer and explanation below:
Post-Call Recovery Reads
Finished your notes? Time to swap the pager for a crown. Kingdoms of Silent Sorrows is the ultimate 'brain-break', a high-stakes fantasy featuring a Fae princess, a Vampire king, and an enemies-to-lovers arc that will actually make you forget about your rounding list. No p-values, just fated mates and forbidden magic.
View on AmazonThe Correct Answer
A
Explanation
Clinical Pearl:
Osteomalacia should be suspected when low bone mineral density is accompanied by diffuse bone tenderness, proximal myopathy, hypophosphatemia, and elevated alkaline phosphatase. Antiresorptive agents such as bisphosphonates are strictly contraindicated in active osteomalacia and hypocalcemia, requiring immediate discontinuation and treatment with high-dose vitamin D and calcium.
Explanation:
This patient has osteomalacia secondary to severe vitamin D and calcium malabsorption following Roux-en-Y gastric bypass, complicated by symptomatic hypocalcemia exacerbated by inappropriate bisphosphonate therapy. The most appropriate next step is to discontinue alendronate and initiate oral ergocalciferol and calcium supplementation, as endocrine society guidance identifies uncorrected hypocalcemia and osteomalacia as absolute contraindications to antiresorptive therapy. Switching to intravenous zoledronic acid is contraindicated because potent parenteral antiresorptive agents abruptly suppress skeletal calcium efflux and cause severe, life-threatening hypocalcemia. Continuing alendronate while prescribing physical therapy inappropriately treats the proximal muscle weakness as simple deconditioning while leaving a harmful medication in place. A tetracycline-labeled bone biopsy is unnecessary and low-value because the patient's surgical history, proximal myopathy, bone tenderness, and classic laboratory profile (hypocalcemia, hypophosphatemia, elevated alkaline phosphatase, elevated parathyroid hormone, and profound vitamin D deficiency) establish the diagnosis non-invasively. Adding teriparatide is contraindicated because osteoanabolic agents cannot mineralize osteoid in the setting of severe substrate deficiency, and continuing the bisphosphonate remains unsafe.
See you tomorrow morning!